ProKidney (MEX:PROK) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney ROE % Adjusted to Book Value?

ProKidney's ROE % for the quarter that ended in Dec. 2024 was 0.00%. ProKidney's PB Ratio for the quarter that ended in Dec. 2024 was N/A. ProKidney's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.

ProKidney ROE % Adjusted to Book Value Historical Data

The historical data trend for ProKidney's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney ROE % Adjusted to Book Value Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of ProKidney's ROE % Adjusted to Book Value

For the Biotechnology subindustry, ProKidney's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProKidney's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProKidney's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ProKidney's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

ProKidney ROE % Adjusted to Book Value Calculation

ProKidney's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

ProKidney's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

ProKidney ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of ProKidney's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

ProKidney Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.